Lidocaine, Xylocaine Flashcards
Lidocaine Class
Antidysrhythmic (Class I-B)
Lidocaine Action
• Decreases ventricular automaticity (reduces the slope of
phase 4 diastolic depolarization)
• Decreases excitability, and raises fibrillation threshold
• Decreases conduction in ischemic cardiac tissue without
adversely affecting normal conduction
• Does not affect contractility
Lidocaine Indications
• Pulseless VT/VF
• VT w/ pulse
• Malignant PVCs
• Wide complex tachycardias of unknown origin
• Pre-Intubation in the setting of closed head injuries and
strokes
Lidocaine Contraindications
- Advanced AV block (2nd degree Type II (Mobitz II) and 3rd degree blocks) in the absence of a functioning pacemaker
- Adams-Stokes syndrome
Lidocaine Precautions
- Hypotension
* Torsades de Pointes (if known torsade’s, magnesium is the agent of choice)
Lidocaine Dosage
Adults:
• Pulseless VT/VF: IV/IO: 1-1.5 mg/kg IV, can repeat in 3-5 min not to exceed 3 mg/kg or 300 mg in 30 minutes.
• Stable VT: 1-1.5 mg/kg slow IV bolus followed by additional doses of 0.5-0.75 mg/kg q 5 min not to exceed 3 mg/kg or 300 mg in 30 minutes.
• Infusion: 1-4 mg/minute titrated for effect.
Pediatrics:
• All Ventricular dysrhythmias: IV/IO: 1 mg/kg bolus, not to exceed 3 mg/kg
• Continuous Infusion: IV/IO: 20-50 µg/kg/min infusion. 120 mg in 100 ml NS yielding 1.2 mg/ml.
Lidocaine Onst/ Duration
- Onset: IV—30-90 sec
* Duration: IV—10-20 min for bolus
Lidocaine Side Effects
- Drowsiness
- Dizziness
- Confusion
- Slurred speech
- Seizures
- Respiratory depression/arrest
- Hypotension
- Dysrhythmias
- Bradycardia
- Cardiac arrest
- N/V
Lidocaine Interactions
Additive cardiac depression and toxicity when used concomitantly with: • Amiodarone •Procainamide • Phenytoin, • Quinidine • BB